Here's Why I'm Avoiding SpaceX Stock After the IPO

The article warns that SpaceX's expected $2 trillion IPO could be the largest in history, but argues the company faces a 129x price-to-sales multiple, slowing revenue growth to 18% in 2025 from 51% in 2024 and 89% in 2023, and a likely $5 billion loss tied to AI spending. It also flags strategic risk from the xAI acquisition and uncertainty over how IPO proceeds would be used. The piece is cautionary commentary on valuation, governance, and IPO underperformance rather than new company-disclosed fundamentals.

Analysis

The biggest second-order effect is not “Space IPO bullish/ bearish,” but a capital-rotation event from narrative scarcity into a late-cycle megacap with diminishing marginal growth. At a $2T valuation, public-market buyers would be underwriting a business that already looks priced for perfection, which compresses future upside and raises the probability of post-listing multiple de-rating if execution merely stays good rather than excellent. That is a setup where the IPO can be mechanically strong on debut while still being structurally poor as a 12-36 month investment.

The AI angle is the more important risk because it changes the stock from a single-theme industrial/space asset into a hybrid capex story with much worse transparency. If the company is forced to fund data centers, model training, and inference infrastructure from a public balance sheet, investors inherit a burn profile that is far more correlated with AI sentiment than with launch cadence or satellite economics. That creates a hidden duration problem: the equity will likely trade like a long-duration AI option, but with lower purity and worse disclosure, making it vulnerable to any slowdown in AI spending or any evidence that the AI pivot is subsidizing the core business rather than enhancing it.

For competitors, the more interesting beneficiaries may be not the obvious space peers but the picks-and-shovels infrastructure stack. Any meaningful AI capex funded through IPO proceeds should flow to GPU, networking, power, and data-center ecosystem names; the article’s setup is modestly constructive for NVDA on incremental demand optics, and potentially for INTC only as a speculative “AI infrastructure” secondary beneficiary, though the linkage is weak. NDAQ is mostly a procedural beneficiary if the IPO is real, but the bigger market impact is that a blockbuster listing can temporarily revive private-markets issuance appetite and compress risk premiums across late-stage venture.

The contrarian view is that the market may be over-anchoring on today’s revenue growth deceleration and missing the optionality embedded in a public currency. If management can use listed equity to buy strategic assets, attract talent, and finance a platform shift, the IPO could become a multi-year re-rating story even from an expensive starting point. But that upside path requires flawless capital allocation; the base case remains that the market will pay up initially and then punish any AI monetization disappointment within 6-18 months.

Key Decisions for Investors

• Fade the listing frenzy via a short-after-lockup strategy in the IPO name: avoid chasing the debut, and look to establish a small short or put spread 30-90 days post-listing if the stock holds above 100x sales with no evidence of AI monetization. Risk/reward favors waiting for insider supply to hit.
• Pair trade: long NVDA / short the new listing on any AI-capex narrative squeeze. If the company is forced to buy compute aggressively, NVDA captures the cleaner demand lever while the IPO carries execution and valuation risk.
• Use NDAQ only as a tactical event trade around listing volume, not a secular long. Buy on pre-IPO pipeline enthusiasm and trim into the first 1-2 weeks of elevated issuance activity; the upside is limited, but flow can support a short-duration move.
• Do not own INTC as a thesis vehicle here; if you want exposure to any spillover from AI infrastructure spending, prefer pure-play beneficiaries with clearer share gain. INTC’s linkage is too indirect to justify event-driven capital.
• For long-only mandates, wait for a post-lockup reset before considering any entry. A 20-30% drawdown from IPO levels would still leave the stock expensive, but it would meaningfully improve the asymmetry versus buying at headline scarcity pricing.